The microbiology diagnostic devices and equipment market size has grown rapidly in recent years. It will grow from $6.43 billion in 2025 to $7.5 billion in 2026 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to expansion of diagnostic laboratory infrastructure, rising incidence of infectious diseases, increased hospital-based testing volumes, improvements in laboratory automation technologies, wider availability of microbiology consumables.
The microbiology diagnostic devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $11.53 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic testing, rising investments in laboratory automation, expansion of molecular and microbiology integration, growing focus on antimicrobial resistance detection, increasing adoption of point-of-care microbiology solutions. Major trends in the forecast period include increasing adoption of automated microbiology analyzers, rising demand for rapid pathogen detection solutions, growing use of high-throughput laboratory instruments, expansion of advanced culture and identification techniques, enhanced focus on laboratory workflow automation.
The increasing prevalence of noncommunicable diseases (NCDs) is anticipated to drive the expansion of the microbiology diagnostic devices and equipment market in the coming years. NCDs are health conditions that are not spread directly from one individual to another and include disorders such as cardiovascular disease, cancer, chronic respiratory disease, and diabetes. The growing burden of NCDs is linked to complications that frequently necessitate laboratory-based microbiological testing to identify infections and monitor patient health. For example, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, it was projected that by 2050, over 35 million new cancer cases would occur, reflecting a 77% rise compared to the estimated 20 million cases in 2022. Consequently, the increasing prevalence of noncommunicable diseases is fueling the growth of the microbiology diagnostic devices and equipment market.
Major companies in the microbiology diagnostic devices and equipment market are introducing innovative systems, such as third-generation total lab automation (TLA) systems, to enhance laboratory testing efficiency, accuracy, and cost-effectiveness. These advanced TLA systems automate various laboratory tasks, from specimen processing and plating to incubation, imaging, and culture reading. Becton, Dickinson, and Company (BD) launched third-generation TLA systems in January 2023, featuring a modular design, a robotic track system, advanced informatics solutions, and integration of artificial intelligence (AI). This system is customizable for a variety of tasks in a microbiology laboratory, making it a valuable tool for laboratories seeking improved efficiency, cost reduction, and enhanced patient care.
In May 2024, bioMérieux, a France-based producer of microbiology and molecular diagnostic systems, formed a partnership with Pfizer Inc. and the Malawi Ministry of Health to improve infectious disease management in Malawi. Through this collaboration, bioMérieux intends to strengthen the country’s diagnostic, surveillance, and antimicrobial stewardship capabilities by utilizing its expertise in microbiology diagnostic devices and equipment. The initiative aims to increase testing capacity and support national efforts to address antimicrobial resistance (AMR). The Malawi Ministry of Health is a central government organization based in Malawi, and Pfizer Inc. is a US-based company focused on innovative medicines and vaccines.
Major companies operating in the microbiology diagnostic devices and equipment market are Danaher, Abbott Laboratories, Thermo Fisher Scientific, Becton Dickinson and Company, Biomerieux, Bio-Rad Laboratories Inc., Roche, Bruker Corporation, Merck KGaA, Siemens Healthcare, Beckman Coulter Inc., Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers, TestLine Clinical Diagnostics s.r.o., Cepheid, Hologic, Meridian Bioscience, Qiagen N.V., Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc., PerkinElmer Inc., Neogen Corporation.
North America was the largest region in the microbiology diagnostics devices and equipment market in 2025. Asia-Pacific was the second largest region in the global microbiology diagnostic devices and equipment market. The regions covered in the microbiology diagnostic devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microbiology diagnostic devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the microbiology diagnostic devices and equipment market by increasing costs of imported analyzers, microscopes, incubators, reagents, and laboratory consumables. Diagnostic laboratories and hospitals in North America and Europe are most affected due to reliance on imported laboratory equipment, while Asia-Pacific faces pricing pressure on consumable exports. These tariffs are increasing operational costs and procurement timelines. However, they are also encouraging domestic manufacturing of laboratory instruments, localized reagent production, and regional supply chain development for microbiology diagnostics.
The microbiology diagnostic devices and equipment market research report is one of a series of new reports that provides microbiology diagnostic devices and equipment market statistics, including microbiology diagnostic devices and equipment industry global market size, regional shares, competitors with a microbiology diagnostic devices and equipment market share, detailed microbiology diagnostic devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the microbiology diagnostic devices and equipment industry. This microbiology diagnostic devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Microbiology diagnostics devices and equipment constitute a comprehensive category encompassing various items utilized in microbiology laboratories for the diagnosis of infectious diseases through the examination of pathogens. These devices and equipment include microscopes, slides, test tubes, Petri dishes, growth media (liquid and solid), inoculation loops, pipettes, tips, incubators, autoclaves, and laminar flow hoods. Some pieces of equipment, such as microscopes and hoods, are permanent fixtures, while others, such as pipette tips, are disposable.
The primary types of microbiology diagnostic devices and equipment comprise laboratory instruments, microbiology analyzers, and reagents and consumables. Laboratory instruments encompass items such as incubators, gram stainers, bacterial colony counters, petri dish fillers, and automated culture systems, which are essential for laboratory operations. Reagents include pathogen-specific kits and general reagents used across various end-users, including diagnostic laboratories, hospitals, and others.
The microbiology diagnostic devices and equipment consists of sales of instruments such as incubators, autoclave sterilizers, anaerobic culture systems, blood culture systems, gram strainers, microscopes, mass spectrometers, molecular diagnostic instruments, reagents pathogen-specific kits, and general reagents for microbiology diagnostic. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The microbiology diagnostic devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $11.53 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic testing, rising investments in laboratory automation, expansion of molecular and microbiology integration, growing focus on antimicrobial resistance detection, increasing adoption of point-of-care microbiology solutions. Major trends in the forecast period include increasing adoption of automated microbiology analyzers, rising demand for rapid pathogen detection solutions, growing use of high-throughput laboratory instruments, expansion of advanced culture and identification techniques, enhanced focus on laboratory workflow automation.
The increasing prevalence of noncommunicable diseases (NCDs) is anticipated to drive the expansion of the microbiology diagnostic devices and equipment market in the coming years. NCDs are health conditions that are not spread directly from one individual to another and include disorders such as cardiovascular disease, cancer, chronic respiratory disease, and diabetes. The growing burden of NCDs is linked to complications that frequently necessitate laboratory-based microbiological testing to identify infections and monitor patient health. For example, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, it was projected that by 2050, over 35 million new cancer cases would occur, reflecting a 77% rise compared to the estimated 20 million cases in 2022. Consequently, the increasing prevalence of noncommunicable diseases is fueling the growth of the microbiology diagnostic devices and equipment market.
Major companies in the microbiology diagnostic devices and equipment market are introducing innovative systems, such as third-generation total lab automation (TLA) systems, to enhance laboratory testing efficiency, accuracy, and cost-effectiveness. These advanced TLA systems automate various laboratory tasks, from specimen processing and plating to incubation, imaging, and culture reading. Becton, Dickinson, and Company (BD) launched third-generation TLA systems in January 2023, featuring a modular design, a robotic track system, advanced informatics solutions, and integration of artificial intelligence (AI). This system is customizable for a variety of tasks in a microbiology laboratory, making it a valuable tool for laboratories seeking improved efficiency, cost reduction, and enhanced patient care.
In May 2024, bioMérieux, a France-based producer of microbiology and molecular diagnostic systems, formed a partnership with Pfizer Inc. and the Malawi Ministry of Health to improve infectious disease management in Malawi. Through this collaboration, bioMérieux intends to strengthen the country’s diagnostic, surveillance, and antimicrobial stewardship capabilities by utilizing its expertise in microbiology diagnostic devices and equipment. The initiative aims to increase testing capacity and support national efforts to address antimicrobial resistance (AMR). The Malawi Ministry of Health is a central government organization based in Malawi, and Pfizer Inc. is a US-based company focused on innovative medicines and vaccines.
Major companies operating in the microbiology diagnostic devices and equipment market are Danaher, Abbott Laboratories, Thermo Fisher Scientific, Becton Dickinson and Company, Biomerieux, Bio-Rad Laboratories Inc., Roche, Bruker Corporation, Merck KGaA, Siemens Healthcare, Beckman Coulter Inc., Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers, TestLine Clinical Diagnostics s.r.o., Cepheid, Hologic, Meridian Bioscience, Qiagen N.V., Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc., PerkinElmer Inc., Neogen Corporation.
North America was the largest region in the microbiology diagnostics devices and equipment market in 2025. Asia-Pacific was the second largest region in the global microbiology diagnostic devices and equipment market. The regions covered in the microbiology diagnostic devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microbiology diagnostic devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the microbiology diagnostic devices and equipment market by increasing costs of imported analyzers, microscopes, incubators, reagents, and laboratory consumables. Diagnostic laboratories and hospitals in North America and Europe are most affected due to reliance on imported laboratory equipment, while Asia-Pacific faces pricing pressure on consumable exports. These tariffs are increasing operational costs and procurement timelines. However, they are also encouraging domestic manufacturing of laboratory instruments, localized reagent production, and regional supply chain development for microbiology diagnostics.
The microbiology diagnostic devices and equipment market research report is one of a series of new reports that provides microbiology diagnostic devices and equipment market statistics, including microbiology diagnostic devices and equipment industry global market size, regional shares, competitors with a microbiology diagnostic devices and equipment market share, detailed microbiology diagnostic devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the microbiology diagnostic devices and equipment industry. This microbiology diagnostic devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Microbiology diagnostics devices and equipment constitute a comprehensive category encompassing various items utilized in microbiology laboratories for the diagnosis of infectious diseases through the examination of pathogens. These devices and equipment include microscopes, slides, test tubes, Petri dishes, growth media (liquid and solid), inoculation loops, pipettes, tips, incubators, autoclaves, and laminar flow hoods. Some pieces of equipment, such as microscopes and hoods, are permanent fixtures, while others, such as pipette tips, are disposable.
The primary types of microbiology diagnostic devices and equipment comprise laboratory instruments, microbiology analyzers, and reagents and consumables. Laboratory instruments encompass items such as incubators, gram stainers, bacterial colony counters, petri dish fillers, and automated culture systems, which are essential for laboratory operations. Reagents include pathogen-specific kits and general reagents used across various end-users, including diagnostic laboratories, hospitals, and others.
The microbiology diagnostic devices and equipment consists of sales of instruments such as incubators, autoclave sterilizers, anaerobic culture systems, blood culture systems, gram strainers, microscopes, mass spectrometers, molecular diagnostic instruments, reagents pathogen-specific kits, and general reagents for microbiology diagnostic. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Microbiology Diagnostic Devices and Equipment Market Characteristics
3. Microbiology Diagnostic Devices and Equipment Market Supply Chain Analysis
4. Global Microbiology Diagnostic Devices and Equipment Market Trends and Strategies
5. Microbiology Diagnostic Devices and Equipment Market Analysis of End Use Industries
7. Global Microbiology Diagnostic Devices and Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Microbiology Diagnostic Devices and Equipment Total Addressable Market (TAM) Analysis for the Market
9. Microbiology Diagnostic Devices and Equipment Market Segmentation
10. Microbiology Diagnostic Devices and Equipment Market Regional and Country Analysis
11. Asia-Pacific Microbiology Diagnostic Devices and Equipment Market
12. China Microbiology Diagnostic Devices and Equipment Market
13. India Microbiology Diagnostic Devices and Equipment Market
14. Japan Microbiology Diagnostic Devices and Equipment Market
15. Australia Microbiology Diagnostic Devices and Equipment Market
16. Indonesia Microbiology Diagnostic Devices and Equipment Market
17. South Korea Microbiology Diagnostic Devices and Equipment Market
18. Taiwan Microbiology Diagnostic Devices and Equipment Market
19. South East Asia Microbiology Diagnostic Devices and Equipment Market
20. Western Europe Microbiology Diagnostic Devices and Equipment Market
21. UK Microbiology Diagnostic Devices and Equipment Market
22. Germany Microbiology Diagnostic Devices and Equipment Market
23. France Microbiology Diagnostic Devices and Equipment Market
24. Italy Microbiology Diagnostic Devices and Equipment Market
25. Spain Microbiology Diagnostic Devices and Equipment Market
26. Eastern Europe Microbiology Diagnostic Devices and Equipment Market
27. Russia Microbiology Diagnostic Devices and Equipment Market
28. North America Microbiology Diagnostic Devices and Equipment Market
29. USA Microbiology Diagnostic Devices and Equipment Market
30. Canada Microbiology Diagnostic Devices and Equipment Market
31. South America Microbiology Diagnostic Devices and Equipment Market
32. Brazil Microbiology Diagnostic Devices and Equipment Market
33. Middle East Microbiology Diagnostic Devices and Equipment Market
34. Africa Microbiology Diagnostic Devices and Equipment Market
36. Microbiology Diagnostic Devices and Equipment Market Competitive Landscape and Company Profiles
37. Microbiology Diagnostic Devices and Equipment Market Other Major and Innovative Companies
40. Microbiology Diagnostic Devices and Equipment Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Microbiology Diagnostic Devices And Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses microbiology diagnostic devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for microbiology diagnostic devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microbiology diagnostic devices and equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Laboratory Instruments; Microbiology Analyzers; Reagents And Consumables2) By Reagents: Pathogen-Specific Kits; General Reagents
3) By End-User: Diagnostic Laboratories; Hospitals; Other End-Users
Subsegments:
1) By Laboratory Instruments: Incubators; Autoclaves And Sterilizers; Refrigerators And Freezers; Centrifuges; Microscopes2) By Microbiology Analyzers: Automated Microbiology Analyzers; Polymerase Chain Reaction (PCR) Analyzers; Mass Spectrometers; Immunoassay Analyzers; Flow Cytometers
3) By Reagents And Consumables: Culture Media; Stains And Dyes; Reagent Kits; Sample Collection Devices; Test Strips And Kits For Specific Pathogens
Companies Mentioned: Danaher; Abbott Laboratories; Thermo Fisher Scientific; Becton Dickinson and Company; Biomerieux; Bio-Rad Laboratories Inc.; Roche; Bruker Corporation; Merck KGaA; Siemens Healthcare; Beckman Coulter Inc.; Ortho Clinical Diagnostics; Sysmex Corporation; Siemens Healthineers; TestLine Clinical Diagnostics s.r.o.; Cepheid; Hologic; Meridian Bioscience; Qiagen N.V.; Immunodiagnostic Systems Holdings PLC; Mesa Biotech Inc.; PerkinElmer Inc.; Neogen Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Microbiology Diagnostic Devices and Equipment market report include:- Danaher
- Abbott Laboratories
- Thermo Fisher Scientific
- Becton Dickinson and Company
- Biomerieux
- Bio-Rad Laboratories Inc.
- Roche
- Bruker Corporation
- Merck KGaA
- Siemens Healthcare
- Beckman Coulter Inc.
- Ortho Clinical Diagnostics
- Sysmex Corporation
- Siemens Healthineers
- TestLine Clinical Diagnostics s.r.o.
- Cepheid
- Hologic
- Meridian Bioscience
- Qiagen N.V.
- Immunodiagnostic Systems Holdings PLC
- Mesa Biotech Inc.
- PerkinElmer Inc.
- Neogen Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 7.5 Billion |
| Forecasted Market Value ( USD | $ 11.53 Billion |
| Compound Annual Growth Rate | 11.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
